Rachel Perry retweeted
A study from @RachelPerryLab1 in @PNASNews shows that working muscles can outcompete tumors for glucose, slowing their growth. The findings also suggest that exercise may play a role in the prevention and treatment of #cancer.
medicine.yale.edu/cancer/new…
@SmilowCancer
Rachel Perry retweeted
Abigail Koomson @RachelPerryLab1 reveals potential metabolic targets to improve quality of life during cancer treatment. Using a mouse model of #breastcancer-related fatigue, physical exhaustion was linked to disrupted muscle metabolism and #inflammation. #AACR26 @YaleBreast @AACR @SmilowCancer @OncoAlert
Rachel Perry retweeted
New research finds that even low levels of physical activity shift glucose away from tumors and toward working muscles, limiting cancer’s fuel supply. "Any amount of activity may be beneficial,” explains @RachelPerryLab1.
medicine.yale.edu/news-artic…
@SmilowCancer
Rachel Perry retweeted
💫NEW: @AnuHemalatha, @valentatormenta, @RachelPerryLab1 & co track the endogenous redox ratio (NAD(P)H/FAD) with live imaging in the mouse skin and find that maintaining a robust redox ratio is key to clonal prevalence.
nature.com/articles/s41556-0…
Rachel Perry retweeted
In a new study, @YaleCancer researchers tracked the initial metabolic response to a pair of #cancer mutations that are typically tolerated in skin.
news.yale.edu/2025/01/06/tra…
@SmilowCancer @YaleMed @YNHH @valentatormenta @RachelPerryLab1 @AnuHemalatha @YaleGenetics
Rachel Perry retweeted
Research has shown that insulin is key to regulating glucose uptake into tumors.
In a new interview, @RachelPerryLab1 discusses the link between insulin & cancer and the future of precision medicine for metabolism-related cancers.
medicine.yale.edu/internal-m…
Rachel Perry retweeted
Tonight at 7:30pm on Yale Cancer Answers, Dr. Rachel Perry @RachelPerryLab1 will discuss a promising new drug that could help treat cancer-related #fatigue. Listen live on @wnpr, download @iTunes, or watch @YouTube. @YaleMed @YNHH @SmilowCancer
Rachel Perry retweeted
Are you an undergrad, postbacc or community student looking for more research experience during the school year (Spring and Fall Semesters) then these are the VIBES for you!
We look forward to reading your applications🤗
Rachel Perry retweeted
A new study from @RachelPerryLab1 + led by Dr. Xinyi Zhang found that a metabolism-targeting drug helped alleviate cancer-related fatigue in mice w/o interfering with treatments for #cancer. #dichloroacetate
@SmilowCancer @YaleMed @YNHH @AJPEndoMetab
yalecancercenter.org/news-ar…
Rachel Perry retweeted
There’s this unfortunate myth in science that the head of the lab alone controls its culture. In reality, all the members do and so each person should realize that they bring their own values, attitudes, and spirit for how things should be and that this does matter quite a bit.
Rachel Perry retweeted
Please join us for next week's #VASCI seminar by @RachelPerryLab1:
Obesity, Immunotherapy, and Cancer: Paradox or Parsimonious?
Dr. Rachel Perry
Yale School of Medicine
Assistant Professor, Medicine/Endocrinology, Cellular & Molecular Physiology
Sept 27, 2023
ISB Rm 221, 4-5pm
Rachel Perry retweeted
By applying high-throughput biological omics techniques, researchers find that organ systems respond uniquely to support liver antioxidant synthesis to fight sepsis.
Read more from #YaleEndocrinology team ⬇️
@BrooksLeitner @RachelPerryLab1
medicine.yale.edu/intmed/new…
Rachel Perry retweeted
First , thank you to my heavenly father for continually honoring me and thank you to my mentors especially @RachelPerryLab1 and @maryam_lustberg for using every opportunity to elevate me. #SMDPScholar #AnnieLefellowship.
Rachel Perry retweeted
A new review @RachelPerryLab1 @mirwin_yale @tarasanftmd and others examines the impact of energy balance on triple negative #breastcancer #TNBC #bcsm. academic.oup.com/jncimono/ar…
@SmilowCancer @YaleMed @YNHH @YaleSPH @YaleBreast @JNCI_Now
Rachel Perry retweeted
I feel honored and humbled to be selected as a Freeman Hrawbowski Scholar. I am grateful to the trainees who joined my lab to share their determination and creativity, the mentors and colleagues who raised me as a scientist, and my family. Thank you HHMI for the support!
This quoted post is unavailable.
Rachel Perry retweeted
This is a critical and often overlooked point. Insulin resistance arises when your cells are no longer "listening" to insulin. The pancreas pumps out even more insulin to overcome the resistance. Cancer cells, meanwhile, will likely be "listening" to insulin the whole time.
Nice meta-analysis by @LykkeSylow et al. Insulin resistance in cancer should create a 2 hit issue: tumors (mostly GLUT1) likely won’t become insulin resistant while other tissues (GLUT4 dependent) do, so lots of insulin (mitogen) and glucose (fuel) around to promote tumor growth!
Rachel Perry retweeted
.@Xinyizh41434765 from @RachelPerryLab1 gave a passionate presentation #AACR23 on Dichloroacetate as a novel pharmaceutical treatment for cancer-related fatigue in #melanoma @AACR @OncoAlert @SmilowCancer @YaleMed
Rachel Perry retweeted
Hi, I'm Lisa! I'm an #immunoengineer currently on the faculty job market.
The Volpatti Lab will combine my training as a @AHA_Research Postdoc Fellow at @UChicagoPME and PhD at @MITChemE to engineer cytokine therapies for metabolic diseases.
ALT Schematic of a plasmid map containing pictures of an atherosclerotic artery, a fatty liver, and a necrotic tumor with the words "Engineering Cytokines for Metabolic Diseases." Around the outside of the plasmid map are the words Targeted, Stimuli-Responsive, and Engineered. Image made with BioRender.com.
Rachel Perry retweeted
Kudos to @NIH for providing $2500/yr in childcare costs to grad students and postdocs on training grants. It doesn’t cover the full cost, but it helps. grants.nih.gov/faqs#/funding…
